Keymed Biosciences Revenue

In the year 2025, Keymed Biosciences had annual revenue of 716.31M CNY with 67.31% growth. Keymed Biosciences had revenue of 217.56M in the half year ending December 31, 2025, with 706.65% growth.

Revenue

716.31M CNY

Revenue Growth

+67.31%

P/S Ratio

27.53

Revenue / Employee

440.81K CNY

Employees

1,625

Market Cap

21.95B HKD

Revenue Chart

* This company reports financials in CNY.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	716.31M	288.19M	67.31%
Dec 31, 2024	428.12M	74.03M	20.91%
Dec 31, 2023	354.10M	254.03M	253.87%
Dec 31, 2022	100.06M	-10.21M	-9.26%
Dec 31, 2021	110.27M	-	-
Dec 31, 2020	Pro	Pro	Pro
Dec 31, 2019	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Zai Lab	3.58B
Duality Biotherapeutics	2.06B
Ascletis Pharma	2.26M
Shanghai Bao Pharmaceuticals	54.70M
InnoCare Pharma	2.87B
Ascentage Pharma Group International	638.89M
Nanjing Leads Biolabs	197.25M
Genscript Biotech	7.47B

Revenue Rankings